Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.

Author: AdaniR, AlbertonF, CorainM, GarofanoA, PangalloL, ValoreA, ZanellaV

Paper Details 
Original Abstract of the Article :
Dupuytren's disease (DD) is a fibroproliferative pathology that affects the palmar aponeurosis causing the development of nodules and collagen cords and the progressive flexion of the fingers. The standard procedure is surgical fasciectomy, followed by high recurrence rates. Collagenase Clostridium ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s12306-013-0304-x

データ提供:米国国立医学図書館(NLM)

Investigating Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture

Dupuytren's disease (DD) is a condition that affects the hand, causing the fingers to bend inward, often limiting mobility and functionality. Traditional treatment for DD has been surgical fasciectomy, but this procedure can be associated with complications and a high recurrence rate. This research explores the effectiveness and safety of a non-invasive treatment option for DD: injection of collagenase Clostridium histolyticum (CCH).

The study, involving 40 patients with DD, evaluated the efficacy and safety of CCH injections performed in an outpatient setting. The researchers found that CCH injections were effective in improving finger extension and reducing the severity of DD. The procedure was also well-tolerated, with minimal side effects and complications. The study concluded that CCH injections represent a promising non-invasive alternative to surgical fasciectomy for treating DD.

Non-Invasive Treatment Options for Dupuytren's Disease

This research provides compelling evidence for the effectiveness and safety of CCH injections in treating DD. The study's findings offer a less invasive and potentially more convenient alternative to surgical intervention. This could benefit patients seeking to avoid the risks and recovery time associated with surgery.

Improving Treatment Options for Dupuytren's Disease

The exploration of non-invasive treatments like CCH injections is a positive development in the management of DD. This research, like a refreshing oasis in the desert of hand-related conditions, offers a new avenue for treating this debilitating disease, potentially improving quality of life for individuals affected by DD.

Dr.Camel's Conclusion

Navigating the challenges of Dupuytren's disease can feel like traversing a treacherous desert landscape. This research, like a well-stocked caravan, provides hope for those seeking a less invasive treatment option. The findings suggest that CCH injections offer a potential path towards regaining hand functionality and improving quality of life.

Date :
  1. Date Completed 2017-08-10
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24254968

DOI: Digital Object Identifier

10.1007/s12306-013-0304-x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.